Trial Profile
Dietary Therapy for Inherited Disorders of Energy Metabolism
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Triheptanoin (Primary)
- Indications Barth syndrome; Lipid metabolism disorders
- Focus Expanded access; Therapeutic Use
- 21 Jan 2021 Status changed from recruiting to completed.
- 16 Jun 2014 New trial record